A First-in-human Clinical Trial to Evaluate an Alpha-radiation Imaging Agent
A First-in-human Clinical Trial to Evaluate an Alpha-radiation Imaging Agent
Active, not recruiting · NCT05111509 · Registry updated 2025-07-14Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A First-in-human Clinical Trial to Evaluate an Alpha-radiation Imaging Agent | Neuroendocrine Tumor Grade 1; Neuroendocrine Tumor Grade 2 | Active, not recruiting | Early phase 1 | 2025-07-14 | NCT05111509 |
4 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Holden Comprehensive Cancer Center | 8 |
| National Cancer Institute (NCI) | 3015 |
| Perspective Therapeutics | 5 |
| Yusuf Menda | 3 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| The University of Iowa | Iowa City | United States | 6 |